Black Friday sale
PTCB Quiz Prep

PTCB Practice Test 1: Free 20-Question Mini Exam

20 questions weighted to the four 2026 PTCE domains, drawn fresh on every start from Test 1's own set of more than 1,200 questions, separate from Test 2. Timed, instantly scored, every answer cited.

Updated · aligned to the 2026 PTCE outline

20 questions25 min timedDraws from 1,241 of our 3,083 questionsInstant resultsNo sign-up100% free

Key takeaways

  • A short 20-question mini exam weighted to the four 2026 PTCE domains.
  • Every start draws a fresh 20 from Test 1's own set of more than 1,200 questions.
  • Test 1 and Test 2 use separate sets, so the two never share a question.

Ready when you are

20 questions · 25 minutes · randomized every attempt, with a cited explanation for every answer.

  • Give yourself 25 focused minutes. The timer won't pause once you begin.
  • Silence your phone and close other tabs so nothing breaks your concentration.
  • Answer from memory. That's how you find the domains that need more review.

About this test

PTCB Practice Test 1 is a 20-question mini exam that mirrors the real PTCE in miniature: the same four knowledge domains in the same proportions as the official 2026 content outline (Medications 35%, Patient Safety 23.75%, Order Entry 22.5%, Federal Requirements 18.75%). It is built for a focused study session or a quick daily rep when you don't have two hours for the full 90-question exam.

Test 1 is not a fixed list of 20 questions. Every time you start it, it draws a fresh 20 at random from its own set of more than 1,200 questions, in the same domain proportions, so a retake is a new test rather than a memory check. With a free account, questions you have not seen yet come first. Test 2 draws from a separate set, so the two never share a question.

Every answer comes with a source-cited explanation, turning a wrong answer into a mini lesson.

New to the material? Work through our 2026 PTCB study guide first, then reinforce it with the full PTCB practice test and PTCB Practice Test 2.

What's in the question bank

TopicQuestions in bank
Escalation69
Side Effects55
Types of prescription errors52
Equipment52
Reporting48
Interactions46
Hygiene39
Look-alike sound-alike drugs32

Sample questions with answers

These 8 questions come straight from the 1,241 questions the timed test above draws from, part of our 3,083-question bank. Work each one before you open the answer: recalling it cold is what moves it into long-term memory.

1. A man is prescribed Flomax (tamsulosin) to improve urine flow. Tamsulosin is most commonly used to treat which condition?

  • A.A urinary tract infection
  • B.Overactive bladder
  • C.Erectile dysfunction
  • D.Benign prostatic hyperplasia (BPH)
Show answer and explanation

Correct answer: D. Benign prostatic hyperplasia (BPH)

Tamsulosin is an alpha blocker that relaxes smooth muscle in the prostate and bladder neck to relieve the urinary symptoms of benign prostatic hyperplasia (BPH). It does not treat infection or erectile dysfunction, so those distractors describe unrelated therapies.

2. Even without the REMS, why does FDA still recommend that prescribers monitor absolute neutrophil count (ANC) in patients taking clozapine (Clozaril)?

  • A.Clozapine commonly causes very high platelet counts
  • B.Clozapine can cause severe neutropenia, a dangerous drop in a type of white blood cell
  • C.Clozapine raises red blood cell counts and thickens the blood
  • D.ANC predicts how well clozapine controls psychosis
Show answer and explanation

Correct answer: B. Clozapine can cause severe neutropenia, a dangerous drop in a type of white blood cell

FDA states that although the clozapine REMS is no longer necessary, the risk of severe neutropenia still exists, and prescribers should monitor ANC as the prescribing information describes. Neutrophils are white blood cells that fight infection. ANC is a safety test, not a measure of how well the drug works.

3. A pharmacy plans to move to a new building across town. According to DEA's Pharmacist's Manual, what should it do before moving its controlled substances?

  • A.Nothing until the next renewal
  • B.Notify the wholesaler of the new delivery address
  • C.Request a modification of its DEA registration first
  • D.Send its unused DEA Forms 222 to the new location
Show answer and explanation

Correct answer: C. Request a modification of its DEA registration first

DEA's Pharmacist's Manual, citing 21 CFR 1301.51(a), says a pharmacy should first request a modification of registration before moving to a new physical location, and modifications must be approved by DEA like applications. Registration is tied to a location (21 CFR 1301.12), so changing only the wholesaler's address or waiting until renewal is not enough.

4. In a failure modes effect analysis (FMEA) of the dispensing process, how does AHRQ PSNet say teams decide which steps to fix first?

  • A.Steps performed by the newest employees are fixed first
  • B.Steps with the highest criticality indices are prioritized for error proofing
  • C.Steps are fixed in alphabetical order
  • D.Only the final verification step is reviewed
Show answer and explanation

Correct answer: B. Steps with the highest criticality indices are prioritized for error proofing

AHRQ PSNet explains that FMEA combines the likelihood of a failure, the chance of detecting it and its impact into a criticality index, and that steps with the highest criticality indices are prioritized for error proofing. Seniority, alphabetical order or looking only at the final check do not rank actual risk.

5. Under 21 CFR 211.204, how must a drug manufacturer's procedures for holding, testing and reprocessing returned drug products be kept?

  • A.In writing, and they must be followed
  • B.Verbally, by the shift supervisor
  • C.Only in the returns processor's files
  • D.They are optional
Show answer and explanation

Correct answer: A. In writing, and they must be followed

21 CFR 211.204 ends by requiring that procedures for the holding, testing and reprocessing of returned drug products be in writing and be followed. Verbal or optional procedures do not meet current good manufacturing practice.

6. Lantus (insulin glargine) is best described as which type of insulin?

  • A.Rapid-acting insulin
  • B.Short-acting (regular) insulin
  • C.Long-acting (basal) insulin
  • D.Intermediate-acting (NPH) insulin
Show answer and explanation

Correct answer: C. Long-acting (basal) insulin

Insulin glargine is a long-acting (basal) insulin that provides a steady background level of insulin over roughly 24 hours. Rapid-acting insulins such as lispro are given at meals to cover food, so they serve a very different purpose from basal insulin.

7. A patient on divalproex (Depakote) is starting lamotrigine for epilepsy. Why does the lamotrigine labeling call for extra caution with this combination?

  • A.Valproate coadministration is a factor that increases the risk of serious lamotrigine rash
  • B.Valproate makes lamotrigine ineffective within a week
  • C.Valproate lowers lamotrigine levels, so a higher starting dose is needed
  • D.The combination commonly causes kidney stones
Show answer and explanation

Correct answer: A. Valproate coadministration is a factor that increases the risk of serious lamotrigine rash

The Lamictal XR label lists coadministration with valproate (valproic acid or divalproex) as a factor that may increase the risk or severity of rash, along with exceeding the recommended starting dose or titration. The other options are not described in the labeling.

8. An independent pharmacy is being sold to another registered pharmacy, including its controlled substance stock. Under 21 CFR 1301.52(d), how far in advance must the selling registrant notify the DEA Special Agent in Charge?

  • A.At least 14 days before the transfer, unless DEA waives it
  • B.At least 60 days before the transfer
  • C.Within 1 business day after the transfer
  • D.No notice is needed if both are registered
Show answer and explanation

Correct answer: A. At least 14 days before the transfer, unless DEA waives it

21 CFR 1301.52(d) requires the registrant discontinuing business by transferring it to another person to give the Special Agent in Charge the required details at least 14 days before the proposed transfer date, unless the Special Agent in Charge waives the time limit. The 60-day figure relates to early renewal, and one business day is the theft or loss notice deadline.

Ready for the full timed run? Scroll back up and start the Practice Test 1, or browse every free PTCB quiz by exam domain.

Key concepts to know

A fresh batch every start

Retake Test 1 as often as you like: each start draws a new random 20 from more than 1,200 questions, so you keep meeting new material instead of recognising answers. Log the domain you miss most across your attempts and drill it with the matching domain quiz.

Same weighting, smaller dose

The 20 questions keep the official proportions: 7 medications, 5 patient safety, 4 order entry, and 4 federal requirements, so your per-domain result is still a meaningful readiness signal.

Practice Test 1: FAQ

How is Practice Test 1 different from the 90-question exam?

It is a 20-question mini version for shorter sessions, weighted to the same four domains. Use the numbered mini tests for quick reps and the 90-question exam to build stamina for the real 110-minute sitting.

Do I get the same 20 questions if I retake Test 1?

No. Every start draws a fresh 20 at random from Test 1's set of more than 1,200 questions. Because the draw is random, a question can repeat now and then. With a free account, questions you have not seen yet come first.

Will Test 1 and Test 2 show me the same questions?

No. Test 1 and Test 2 draw from separate question sets, so the two never share a question.

Official sources checked

This quiz's exam facts were checked against the sources below. Verify current exam facts directly with PTCB.

More free PTCB practice tests

PTCB Quiz Prep is an independent study resource and is not affiliated with the Pharmacy Technician Certification Board.